Zydus Cadila gets USFDA approval to market generic schizophrenia drug Perphenazine

Zydus Cadila said it has 284 approvals and has so far filed over 386 abbreviated new drug applications (ANDAs) since the commencement of its filing process in the financial year 2003-2004.

FP Trending|Apr 08, 2020, 13:21:11 IST

Pharma company Zydus Cadila has said it has received final approval from United States Food and Drug Administration (USFDA) to market generic Perphenazine tablets, used in the treatment of schizophrenia.The drug is also used for the control of severe nausea and vomiting in adults.USFDA has given its final nod to the company to market Perphenazine tablets USP in the strengths of 2 mg, 4 mg, 8 mg and 16 mg, Zydus Cadila said in a statement.[caption id="attachment_7255541" align="alignleft" width="380"]

Representative image. Image source: Pixabay[/caption]The USFDA is tasked with promoting public health through the control and supervision of several verticals including over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals and others.“The drug will be manufactured at the group’s formulation manufacturing facility at Baddi [,” the statement added.Zydus Cadila said it has 284 approvals and has so far filed over 386 abbreviated new drug applications (ANDAs) since the commencement of its filing process in the financial year 2003-2004.On Tuesday, the pharma major announced on Twitter that it is producing Hydroxychloroquine, in large quantities to be used in the “treatment of coronavirus.” The company also said that it is working on developing a vaccine which will be a long term solution for COVID-19.

India on Tuesday decided to partially lift the ban on Hydroxychloroquine export, news agency PTI reported quoting officials.US President Donald Trump had requested Prime Minister Narendra Modi to release the amount of Hydroxychloroquine ordered by the US after India on 25 March banned the export of the drug.

Stroke is rising among young adults. Doctor explains why it's happening and what you must do

Stroke is increasingly affecting adults in their 30s, 40s and 50s. Experts say unhealthy lifestyles, undiagnosed high blood pressure and delayed treatment are driving the rise in younger stroke cases

3 min read

Stroke in young adults, silent symptoms and late diagnosis: India's growing brain health challenge

Neurologists warn that stroke is increasingly affecting people in their 30s and 40s, while many brain disorders progress silently before symptoms appear. They say early diagnosis, timely referrals and healthier lifestyles are key to reducing India's growing neurological disease burden.

5 min read

Brain tumours aren't always fatal, but delayed diagnosis can be: Experts explain the key warning signs

Brain tumours are frequently mistaken for common headaches, stress or age-related cognitive changes. Doctors say recognising warning signs early and adopting a brain-healthy lifestyle can improve outcomes and reduce the risk of long-term neurological complications.

2 min read

Spices, health and the Indian plate: Why chilli can be good for you—but moderation is still key

From boosting metabolism to supporting heart health, chillies offer several surprising health benefits. But experts say the amount you eat matters, and too much spice can do more harm than good.

4 min read

Organ donation: 5 myths you need to stop believing, according to a transplant specialist

Organ donation has the power to transform and save lives, but this can happen only when myths are replaced with facts. Building awareness, having open conversations and understanding the process can help families make informed decisions.